bpc-157 periodontal regeneration clinical trial bpc 157 🦷 & TB-500: Experimental peptides showing preclinical promise for faster oral healing, reduced gum inflammation & bone support in animal studies. Not FDA-approved for dentistry — research only Peptides in Dentistry: Real Use

These include the severity of deficiency, patient age, and malabsorption issues

Mazdutide Trial Findings 80.2% reduction in liver fat after 48 weeks 73.3% reduction seen in earlier trials Particularly effective for MAFLD (very common in Asian populations) Source: Ji et al., 2025

Despite the presence of some growth factors, platelet-derived preparations were removed from the Prohibited List as studies do not demonstrate any performance enhancement beyond a potential therapeutic effect

Selected Clinical Trial Activity BPC-157 + TB-500 is a research-grade compound that has been studied in laboratory settings but has not undergone full clinical development

Is Retatrutide Approved By The FDA

Notice how the same 10 mg dose can be 200 units, 100 units, 50 units, 33 units, or 25 units depending on nothing more than which vial you are holding